# Comparison of Generic and Original Formulation of Clopidogrel

> **NCT01147133** · PHASE4 · COMPLETED · sponsor: **University of Pecs** · enrollment: 75 (actual)

## Conditions studied

- Coronary Heart Disease
- Percutaneous Coronary Intervention

## Interventions

- **DRUG:** Plavix
- **DRUG:** Kardogrel

## Key facts

- **NCT ID:** NCT01147133
- **Lead sponsor:** University of Pecs
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-04
- **Final completion:** 2010-05
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2013-01-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01147133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01147133, "Comparison of Generic and Original Formulation of Clopidogrel". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01147133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*